tm logo
JYNARQUE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 24 Oct 2024

Last Applicant/ Owned by

2-9 Kanda-Tsukasamachi,

Chiyoda-ku, Tokyo

JP

101-8535

Serial Number

87632640 filed on 03rd Oct 2017

Registration Number

5482786 registered on 29th May 2018

in the Principal Register

Correspondent Address

Scott S. Havlick

Scott S. Havlick HOLLAND & HART LLP

ATTN: TRADEMARK DOCKETING

DENVER, CO 80201

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

JYNARQUE

Pharmaceutical preparations for the treatment of polycystic kidney disease (PKD)

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of polycystic kidney disease (PKD)


First Use Date in General

15th Mar 2018

First Use Date in Commerce

15th Mar 2018

Mark Details


Serial Number

No 87632640

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 57182.0303

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Oct 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24th Oct 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24th Oct 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st May 2024TEAS SECTION 8 & 15 RECEIVED
29th May 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29th May 2018REGISTERED-PRINCIPAL REGISTER
24th Apr 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23rd Apr 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04th Apr 2018STATEMENT OF USE PROCESSING COMPLETE
04th Apr 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL